Segment Information (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
|---|
| Segment Reporting [Abstract] |
|
| Schedule of Segment Reporting Information, by Segment |
The following table summarizes select operating results for each reportable segment (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
| (In millions) |
For Year Ended December 31, 2023 |
|
For Year Ended December 31, 2022 |
|
From
October 20, 2021
through
December 31, 2021 |
|
|
From
July 1, 2021 through
October 19, 2021 |
|
For Year Ended June 30. 2021 |
| Revenues |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
284.5 |
|
|
$ |
271.7 |
|
|
$ |
49.2 |
|
|
|
$ |
60.3 |
|
|
$ |
155.7 |
|
| Technologies |
516.4 |
|
|
446.1 |
|
|
104.9 |
|
|
|
107.7 |
|
|
455.9 |
|
| Consolidated Revenues |
$ |
800.9 |
|
|
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
| Segment Income (Loss) from Operations |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
13.0 |
|
|
$ |
(98.9) |
|
|
$ |
(5.4) |
|
|
|
$ |
(1.8) |
|
|
$ |
2.3 |
|
| Technologies |
46.0 |
|
|
(103.1) |
|
|
(0.8) |
|
|
|
8.2 |
|
|
68.1 |
|
| Total Segment Income (Loss) from Operations |
59.0 |
|
|
(202.0) |
|
|
(6.2) |
|
|
|
6.4 |
|
|
70.4 |
|
| Corporate and other |
(80.9) |
|
|
(95.8) |
|
|
(16.7) |
|
|
|
(48.0) |
|
|
(59.2) |
|
| Consolidated (Loss) Income from Operations |
$ |
(21.9) |
|
|
$ |
(297.8) |
|
|
$ |
(22.9) |
|
|
|
$ |
(41.6) |
|
|
$ |
11.2 |
|
| Capital Expenditures |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
21.8 |
|
|
$ |
22.6 |
|
|
$ |
3.8 |
|
|
|
$ |
6.8 |
|
|
$ |
14.2 |
|
| Technologies |
18.0 |
|
|
11.6 |
|
|
2.0 |
|
|
|
2.7 |
|
|
12.2 |
|
| Total operating and reportable segments |
39.8 |
|
|
34.2 |
|
|
5.8 |
|
|
|
9.5 |
|
|
26.4 |
|
| Corporate and other |
1.0 |
|
|
0.4 |
|
|
0.3 |
|
|
|
0.3 |
|
|
— |
|
| Total Capital Expenditures |
$ |
40.8 |
|
|
$ |
34.6 |
|
|
$ |
6.1 |
|
|
|
$ |
9.8 |
|
|
$ |
26.4 |
|
| Depreciation and Amortization |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
75.2 |
|
|
$ |
82.4 |
|
|
$ |
17.0 |
|
|
|
$ |
13.3 |
|
|
$ |
33.3 |
|
| Technologies |
86.9 |
|
|
91.1 |
|
|
20.1 |
|
|
|
12.4 |
|
|
49.7 |
|
| Total operating and reportable segments |
162.1 |
|
|
173.5 |
|
|
37.1 |
|
|
|
25.7 |
|
|
83.0 |
|
| Corporate and other |
0.7 |
|
|
1.0 |
|
|
0.2 |
|
|
|
0.2 |
|
|
0.6 |
|
| Total Depreciation and Amortization |
$ |
162.8 |
|
|
$ |
174.5 |
|
|
$ |
37.3 |
|
|
|
$ |
25.9 |
|
|
$ |
83.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revenue from External Customers by Geographic Areas |
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
Fiscal Year Ended
December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
2023 |
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
| North America |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
258.1 |
|
|
$ |
252.0 |
|
|
$ |
45.3 |
|
|
|
$ |
54.6 |
|
|
$ |
138.6 |
|
| Technologies |
254.2 |
|
|
210.7 |
|
|
47.6 |
|
|
|
53.4 |
|
|
199.4 |
|
| Total North America |
512.3 |
|
|
462.7 |
|
|
92.9 |
|
|
|
108.0 |
|
|
338.0 |
|
| Europe |
|
|
|
|
|
|
|
|
|
|
| Medical |
26.4 |
|
|
19.7 |
|
|
3.9 |
|
|
|
5.7 |
|
|
17.1 |
|
| Technologies |
245.7 |
|
|
222.1 |
|
|
55.3 |
|
|
|
52.6 |
|
|
241.5 |
|
| Total Europe |
272.1 |
|
|
241.8 |
|
|
59.2 |
|
|
|
58.3 |
|
|
258.6 |
|
| Asia Pacific |
|
|
|
|
|
|
|
|
|
|
| Medical |
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
| Technologies |
16.5 |
|
|
13.3 |
|
|
2.0 |
|
|
|
1.7 |
|
|
15.0 |
|
| Total Asia Pacific |
16.5 |
|
|
13.3 |
|
|
2.0 |
|
|
|
1.7 |
|
|
15.0 |
|
| Total Revenues |
$ |
800.9 |
|
|
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
| Schedule of Revenue by Timing of Recognition |
The following details revenues by timing of recognition (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
Fiscal Year Ended
December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
|
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
| Point in time |
$ |
496.0 |
|
|
$ |
485.9 |
|
|
$ |
120.1 |
|
|
|
$ |
123.6 |
|
|
$ |
456.6 |
|
| Over time |
304.9 |
|
|
231.9 |
|
|
34.0 |
|
|
|
44.4 |
|
|
155.0 |
|
| Total revenues |
$ |
800.9 |
|
|
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
| Revenue from External Customers by Products and Services |
The following details revenues by product category (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
Successor |
|
|
Predecessor |
|
Fiscal Year Ended December 31, |
|
Fiscal Year Ended
December 31, |
|
From October 20, 2021 through December 31 |
|
|
From July 1, 2021 through October 19, |
|
For the Fiscal Year Ended June 30, |
|
2023 |
|
2022 |
|
2021 |
|
|
2021 |
|
2021 |
| Medical segment: |
|
|
|
|
|
|
|
|
|
|
| Medical |
$ |
284.5 |
|
|
$ |
271.7 |
|
|
$ |
49.2 |
|
|
|
$ |
60.3 |
|
|
$ |
155.7 |
|
| Technologies segment: |
|
|
|
|
|
|
|
|
|
|
| Reactor Safety and Control Systems |
204.0 |
|
|
163.8 |
|
|
30.6 |
|
|
|
34.7 |
|
|
146.8 |
|
| Radiological Search, Measurement, and Analysis Systems |
312.4 |
|
|
282.3 |
|
|
74.3 |
|
|
|
73.0 |
|
|
309.1 |
|
| Total Revenues |
$ |
800.9 |
|
|
$ |
717.8 |
|
|
$ |
154.1 |
|
|
|
$ |
168.0 |
|
|
$ |
611.6 |
|
|
| Schedule of Property, Plant, and Equipment by Geographical Areas |
The following details property, plant, and equipment, net, by geography (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, Plant, and Equipment, Net |
| (In millions) |
As of December 31, 2023 |
|
As of
December 31, 2022 |
| North America |
$ |
82.9 |
|
|
$ |
79.4 |
|
| Europe |
51.5 |
|
|
44.7 |
|
| Asia Pacific |
0.1 |
|
|
0.2 |
|
| Total |
$ |
134.5 |
|
|
$ |
124.3 |
|
|